Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus

X
Trial Profile

A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus

Status: Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Riboflavin (Primary)
  • Indications Keratoconus
  • Focus Therapeutic Use
  • Acronyms EVOKE
  • Most Recent Events

    • 12 Jan 2023 According to ClinicalTrials.gov record, protocol has been amended to increase patient number from 10 to 216. Masking will be Double blind now instead of Open Label. Primary endpoint and number of arms are also changed, Randomization will be done.
    • 12 Jan 2023 Planned number of patients changed from 10 to 216.
    • 12 Jan 2023 Planned End Date changed from 1 Jan 2024 to 30 Nov 2028.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top